FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990433376> ?p ?o ?g. }

• W2990433376 endingPage "109648" @default.
• W2990433376 startingPage "109648" @default.
• W2990433376 abstract "Malignant cells frequently demonstrate an oncogenic-driven reliance on glycolytic metabolism to support their highly proliferative nature. Overexpression of pyruvate dehydrogenase kinase (PDK) may promote this unique metabolic signature of tumor cells by inhibiting mitochondrial function. PDKs function to phosphorylate and inhibit pyruvate dehydrogenase (PDH) activity. Silencing of PDK expression has previously been shown to restore mitochondrial function and reduce tumor cell proliferation. High dose Vitamin B1, or thiamine, possesses antitumor properties related to its capacity to reduce PDH phosphorylation and promote its enzymatic activity, presumably through PDK inhibition. Though a promising nutraceutical approach for cancer therapy, thiamine’s low bioavailability may limit clinical effectiveness. Here, we have demonstrated exploiting the commercially available lipophilic thiamine analogs sulbutiamine and benfotiamine increases thiamine’s anti-cancer effect in vitro. Determined by crystal violet proliferation assays, both sulbutiamine and benfotiamine reduced thiamine’s millimolar IC50 value to micromolar equivalents. HPLC analysis revealed that sulbutiamine and benfotiamine significantly increased intracellular thiamine and TPP concentrations in vitro, corresponding with reduced levels of PDH phosphorylation. Through an ex vitro kinase screen, thiamine’s activated cofactor form thiamine pyrophosphate (TPP) was found to inhibit the function of multiple PDK isoforms. Attempts to maximize intracellular TPP by exploiting thiamine homeostasis gene expression resulted in enhanced apoptosis in tumor cells. Based on our in vitro evaluations, we conclude that TPP serves as the active species mediating thiamine’s inhibitory effect on tumor cell proliferation. Pharmacologic administration of benfotiamine, but not sulbutiamine, reduced tumor growth in a subcutaneous xenograft mouse model. It remains unclear if benfotiamine’s effects in vivo are associated with PDK inhibition or through an alternative mechanism of action. Future work will aim to define the action of lipophilic thiamine mimetics in vivo in order to translate their clinical usefulness as anticancer strategies." @default.
• W2990433376 created "2019-12-05" @default.
• W2990433376 creator A5004275264 @default.
• W2990433376 creator A5008121190 @default.
• W2990433376 creator A5039622853 @default.
• W2990433376 creator A5039679854 @default.
• W2990433376 creator A5060299696 @default.
• W2990433376 creator A5062305979 @default.
• W2990433376 creator A5084653723 @default.
• W2990433376 date "2020-01-01" @default.
• W2990433376 modified "2023-09-26" @default.
• W2990433376 title "Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy" @default.
• W2990433376 cites W1484792585 @default.
• W2990433376 cites W1891911041 @default.
• W2990433376 cites W1940014006 @default.
• W2990433376 cites W1949250268 @default.
• W2990433376 cites W1964940095 @default.
• W2990433376 cites W1976463362 @default.
• W2990433376 cites W1979423209 @default.
• W2990433376 cites W1982888615 @default.
• W2990433376 cites W1984020924 @default.
• W2990433376 cites W1991839455 @default.
• W2990433376 cites W1994687037 @default.
• W2990433376 cites W2000542942 @default.
• W2990433376 cites W2001266743 @default.
• W2990433376 cites W2005449470 @default.
• W2990433376 cites W2009976093 @default.
• W2990433376 cites W2011352354 @default.
• W2990433376 cites W2018971639 @default.
• W2990433376 cites W2025315091 @default.
• W2990433376 cites W2028897202 @default.
• W2990433376 cites W2039134299 @default.
• W2990433376 cites W2041096022 @default.
• W2990433376 cites W2058691572 @default.
• W2990433376 cites W2071218376 @default.
• W2990433376 cites W2077893656 @default.
• W2990433376 cites W2090381915 @default.
• W2990433376 cites W2096618924 @default.
• W2990433376 cites W2111713222 @default.
• W2990433376 cites W2116094406 @default.
• W2990433376 cites W2119115728 @default.
• W2990433376 cites W2122343308 @default.
• W2990433376 cites W2122918648 @default.
• W2990433376 cites W2135347204 @default.
• W2990433376 cites W2135606826 @default.
• W2990433376 cites W2140968862 @default.
• W2990433376 cites W2144285975 @default.
• W2990433376 cites W2145455011 @default.
• W2990433376 cites W2151260260 @default.
• W2990433376 cites W2169435493 @default.
• W2990433376 cites W2218000911 @default.
• W2990433376 cites W2259743738 @default.
• W2990433376 cites W2461484379 @default.
• W2990433376 cites W2766997579 @default.
• W2990433376 cites W2806162264 @default.
• W2990433376 cites W2808061953 @default.
• W2990433376 cites W2808184785 @default.
• W2990433376 cites W2896084959 @default.
• W2990433376 doi "https://doi.org/10.1016/j.biopha.2019.109648" @default.
• W2990433376 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31810115" @default.
• W2990433376 hasPublicationYear "2020" @default.
• W2990433376 type Work @default.
• W2990433376 sameAs 2990433376 @default.
• W2990433376 citedByCount "10" @default.
• W2990433376 countsByYear W29904333762020 @default.
• W2990433376 countsByYear W29904333762021 @default.
• W2990433376 countsByYear W29904333762022 @default.
• W2990433376 countsByYear W29904333762023 @default.
• W2990433376 crossrefType "journal-article" @default.
• W2990433376 hasAuthorship W2990433376A5004275264 @default.
• W2990433376 hasAuthorship W2990433376A5008121190 @default.
• W2990433376 hasAuthorship W2990433376A5039622853 @default.
• W2990433376 hasAuthorship W2990433376A5039679854 @default.
• W2990433376 hasAuthorship W2990433376A5060299696 @default.
• W2990433376 hasAuthorship W2990433376A5062305979 @default.
• W2990433376 hasAuthorship W2990433376A5084653723 @default.
• W2990433376 hasBestOaLocation W29904333761 @default.
• W2990433376 hasConcept C121608353 @default.
• W2990433376 hasConcept C126322002 @default.
• W2990433376 hasConcept C134018914 @default.
• W2990433376 hasConcept C181199279 @default.
• W2990433376 hasConcept C184235292 @default.
• W2990433376 hasConcept C185592680 @default.
• W2990433376 hasConcept C190283241 @default.
• W2990433376 hasConcept C2776203871 @default.
• W2990433376 hasConcept C3020471959 @default.
• W2990433376 hasConcept C55493867 @default.
• W2990433376 hasConcept C62112901 @default.
• W2990433376 hasConcept C71924100 @default.
• W2990433376 hasConcept C75217442 @default.
• W2990433376 hasConcept C86803240 @default.
• W2990433376 hasConcept C88099638 @default.
• W2990433376 hasConcept C9506865 @default.
• W2990433376 hasConcept C96232424 @default.
• W2990433376 hasConcept C98274493 @default.
• W2990433376 hasConceptScore W2990433376C121608353 @default.
• W2990433376 hasConceptScore W2990433376C126322002 @default.
• W2990433376 hasConceptScore W2990433376C134018914 @default.

• next